Zidesamtinib demonstrates 94% response rate in TKI-naive patients with advanced ROS1-positive NSCLC
Reports and Proceedings
Reports and Proceedings
Latest News Releases
Updates every hour. Last Updated: 24-Oct-2026 12:17 ET (24-Oct-2026 16:17 GMT/UTC)
Reports and Proceedings
In the PAPILLON study, first-line amivantamab-chemotherapy demonstrates the longest overall survival reported for EGFR exon 20 insertion-positive advanced NSCLC
Reports and Proceedings
New analysis points to low overdiagnosis in breast cancer screening
Peer-Reviewed Publication
Phase III MAVERICK trial supports brain MRI surveillance alone as standard of care for small-cell lung cancer
Reports and Proceedings
Phase III TAISHAN-302 trial shows Tam-Peli significantly improves survival in relapsed small-cell lung cancer
Reports and Proceedings
Phase III ARTEMIS-008 trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer
Reports and Proceedings
Sacituzumab govitecan plus pembrolizumab does not meet primary endpoints in first-line PD-L1-high metastatic NSCLC
Reports and Proceedings
Perioperative atezolizumab plus chemotherapy more than doubles event-free survival in resectable stage II–IIIB NSCLC
Reports and Proceedings
Phase 1 study supports recommended phase 3 dose for investigational EGFR x HER3 antibody-drug conjugate in EGFR-mutated lung cancer
Reports and Proceedings
Pumitamig plus elfetabart drozuntecan shows encouraging early activity in small cell lung cancer
Reports and Proceedings